CIK 0002012593
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880724208
- Phone
- +1 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- Open-market buys, last 90 days
- $22,023,904
- in 7 filings
- Open-market sales, last 90 days
- $4,470,180
- in 7 filings, $4.5M under 10b5-1 plans
Net +$17,553,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-22 | PAUL STEVEN M Director | Purchase | +35,714 | $27.28 | $974K | 77,380 |
| 2026-06-10 | PAUL STEVEN M Director | Grant or award · Stock Option (Right to Buy) | +15,200 | 15,200 | ||
| 2025-09-12 | PAUL STEVEN M Director | Purchase | +28,284 | $24.50 | $693K | 28,284 |
| 2025-09-12 | PAUL STEVEN M Director | Purchase | +13,382 | $24.97 | $334K | 41,666 |
| 2025-06-17 | PAUL STEVEN M Director | Grant or award · Stock Option (Right to Buy) | +21,850 | 21,850 |
Page 1 of 1 · 5 trades